EPISODE · Sep 6, 2024 · 1 MIN
Are CGRP mAbs Cost Effective?
from Migraine Minute News Update
A study found that anti-CGRP monoclonal antibodies not only reduced absenteeism & presenteeism in Spain, they were found to be cost-effective too. Read more: http://bit.ly/3S1KS5Y Image courtesy: DOI 10.1186/s10194-024-01727-0
Embed this episode
NOW PLAYING
Are CGRP mAbs Cost Effective?
0:00
1:11
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Migraine Minute News Update?
This episode is 1 minute long.
When was this Migraine Minute News Update episode published?
This episode was published on September 6, 2024.
Can I download this Migraine Minute News Update episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!